专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

31. 发明申请

US20100075201A1 FUEL CELL WITH ELECTRODE HAVING AN ELECTRICALLY CONDUCTIVE NANO-COLUMN AND PRODUCTION METHOD THEREOF 失效
标题翻译：具有电导电纳米柱的电极的燃料电池及其制造方法
公开(公告)号：US20100075201A1
公开(公告)日：2010-03-25
申请号：US12293667
申请日：2007-03-15
申请人： Haruyuki Nakanishi , Chikashi Inazumi , Yuki Sairyo , Momoyo Sawai , Kenji Yoshikawa , Tomoya Yamashita
发明人： Haruyuki Nakanishi , Chikashi Inazumi , Yuki Sairyo , Momoyo Sawai , Kenji Yoshikawa , Tomoya Yamashita
IPC分类号： H01M4/00 , H01M4/88
CPC分类号： H01M4/8657 , H01M4/8605 , H01M4/92 , H01M4/926 , H01M8/1004 , Y02P70/56
摘要： In a fuel cell including an electrolyte membrane and a pair of electrodes disposed on both sides of the electrolyte membrane, at least one of the electrodes has an electrically conductive nanocolumn that is oriented with an inclination of 60° or less with respect to a planar direction of the electrolyte membrane, a catalyst supported on the electrically conductive nanocolumn, and an electrolyte resin coating the electrically conductive nanocolumn.
摘要翻译：在包括电解质膜和设置在电解质膜的两侧的一对电极的燃料电池中，至少一个电极具有相对于平面方向倾斜60°或更小的导电纳米柱的电解质膜，负载在导电性纳米柱上的催化剂和涂覆导电性纳米柱的电解质树脂。

32. 发明申请

US20090281074A1 DRUG COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING THROMBOSIS OR EMBOLISM 审中-公开
标题翻译：药物组合物和预防和治疗血栓形成或栓塞的方法
公开(公告)号：US20090281074A1
公开(公告)日：2009-11-12
申请号：US12250586
申请日：2008-10-14
申请人： Toshiharu OHTA , Satoshi Komoriya , Toshiharu Yoshino , Kouichi Outo , Yumi Nakamoto , Hiroyuki Naito , Akiyoshi Mochizuki , Tsutomu Nagata , Hideyuki Kanno , Noriyasu Haginoya , Kenji Yoshikawa , Masatoshi Nagamochi , Syozo Kobayashi , Makoto Ono
发明人： Toshiharu OHTA , Satoshi Komoriya , Toshiharu Yoshino , Kouichi Outo , Yumi Nakamoto , Hiroyuki Naito , Akiyoshi Mochizuki , Tsutomu Nagata , Hideyuki Kanno , Noriyasu Haginoya , Kenji Yoshikawa , Masatoshi Nagamochi , Syozo Kobayashi , Makoto Ono
IPC分类号： A61K31/397 , A61K31/437 , A61K31/502 , A61K31/5377 , A61K31/55
CPC分类号： C07D498/04 , C07D213/75 , C07D401/12 , C07D401/14 , C07D409/04 , C07D409/12 , C07D413/12 , C07D413/14 , C07D417/14 , C07D471/04 , C07D487/04 , C07D513/14 , C07D519/00
摘要： Drug compositions containing a substituted diamine compound represented by formula (1): Q1-Q2-r-N(R1)-Q3-N(R2) (1) wherein Q3 represents the following group wherein Q5 represents an alkylene group having 4 carbon atoms, R3 represents a hydrogen atom, and R4 represents a 3-6 membered heterocyclic group which may be substituted; are useful for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after artificial valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.
摘要翻译：含有式（1）表示的取代二胺化合物的药物组合物：Q1-Q2-rN（R1）-Q3-N（R2）（1）其中Q3表示以下基团，其中Q5表示具有4个碳原子的亚烷基，R3 表示氢原子，R4表示可以被取代的3-6元杂环基; 可用于预防和/或治疗脑梗死，脑栓塞，心肌梗死，心绞痛，肺梗塞，肺栓塞，Buerger病，深静脉血栓形成，弥散性血管内凝血综合征，人工瓣膜或关节置换后血栓形成，血栓形成和血管成形术后再闭塞，全身炎症反应综合征（SIRS），多器官功能障碍综合征（MODS），体外循环期间的血栓形成或血液抽血时的凝血。

33. 发明申请

US20090080483A1 SEMICONDUCTOR LASER DEVICE AND MANUFACTURING METHOD THEREOF 有权
标题翻译：半导体激光器件及其制造方法
公开(公告)号：US20090080483A1
公开(公告)日：2009-03-26
申请号：US12166688
申请日：2008-07-02
申请人： Takayuki Kashima , Kouji Makita , Kenji Yoshikawa
发明人： Takayuki Kashima , Kouji Makita , Kenji Yoshikawa
IPC分类号： H01S5/42 , H01S5/00 , H01L21/02
CPC分类号： H01S5/4031 , B82Y20/00 , H01S5/162 , H01S5/22 , H01S5/34313 , H01S5/34326 , H01S5/4087 , H01S2301/173
摘要： A semiconductor laser device includes a first semiconductor laser element and a second semiconductor laser element. The first semiconductor laser element has a first end face window structure that is a region including first impurities formed near an end face, and the second semiconductor laser element has a second end face window structure that is a region including second impurities formed near an end face. The distance from a lower end of a first active layer to a lower end of the first end face window structure is shorter than the distance from a lower end of a second active layer to a lower end of the second end face window structure.
摘要翻译：半导体激光装置包括第一半导体激光元件和第二半导体激光元件。第一半导体激光元件具有第一端面窗结构，该第一端面窗结构是包括在端面附近形成的第一杂质的区域，第二半导体激光元件具有第二端面窗结构，该第二端面窗结构是包括形成在端面附近的第二杂质的区域。从第一有源层的下端到第一端面窗结构的下端的距离比从第二活性层的下端到第二端面窗结构的下端的距离短。

34. 发明授权

US07342014B2 Diamine derivatives 有权
标题翻译：二胺衍生物
公开(公告)号：US07342014B2
公开(公告)日：2008-03-11
申请号：US10773344
申请日：2004-02-09
申请人： Toshiharu Ohta , Satoshi Komoriya , Toshiharu Yoshino , Kouichi Uoto , Yumi Nakamoto , Hiroyuki Naito , Akiyoshi Mochizuki , Tsutomu Nagata , Hideyuki Kanno , Noriyasu Haginoya , Kenji Yoshikawa , Masatoshi Nagamochi , Syozo Kobayashi , Makoto Ono
发明人： Toshiharu Ohta , Satoshi Komoriya , Toshiharu Yoshino , Kouichi Uoto , Yumi Nakamoto , Hiroyuki Naito , Akiyoshi Mochizuki , Tsutomu Nagata , Hideyuki Kanno , Noriyasu Haginoya , Kenji Yoshikawa , Masatoshi Nagamochi , Syozo Kobayashi , Makoto Ono
IPC分类号： A61K31/50 , A61K31/44 , A61K31/445 , C07D471/02 , C07D401/00
CPC分类号： C07D513/04 , C07D209/42
摘要： A compound represented by the general formula (1): Q1-Q2-T0-N(R1)-Q3-N(R2)-T1-Q4 (1) wherein R1 and R2 are hydrogen atoms or the like; Q1 is a saturated or unsaturated, 5- or 6-membered cyclic hydrocarbon group which may be substituted, or the like; Q2 is a single bond or the like; Q3 is a group in which Q5 is an alkylene group having 1 to 8 carbon atoms, or the like; and T0 and T1 are carbonyl groups or the like; a salt thereof, a solvate thereof, or an N-oxide thereof. The compound is useful as an agent for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.
摘要翻译：由通式（1）表示的化合物：<？in-line-formula description =“In-line Formulas”end =“lead”？> Q ^{1 -N（R 1） - N（R 2） - N（R 2） - T （1）<？in-line-formula description =“In-line Formulas”end =“tail”？>其中R 1 < / SUP>和R 2是氢原子等; Q 1是可被取代的饱和或不饱和的5或6元环烃基，等等; Q 2是单键等; Q 3是其中Q 5是具有1〜8个碳原子的亚烷基等的基团; T 0和T 1是羰基等; 其盐，其溶剂合物或其N-氧化物。该化合物可用作预防和/或治疗脑梗塞，脑栓塞，心肌梗死，心绞痛，肺梗塞，肺栓塞，Buerger病，深静脉血栓形成，弥散性血管内凝血综合征，瓣膜或关节置换后血栓形成，血管成形术后的血栓形成和再闭塞，全身炎症反应综合征（SIRS），多器官功能障碍综合征（MODS），体外循环期间的血栓形成或血液抽血时的凝血。}

35. 发明申请

US20050245565A1 Diamine derivatives 审中-公开
标题翻译：二胺衍生物
公开(公告)号：US20050245565A1
公开(公告)日：2005-11-03
申请号：US10481629
申请日：2002-06-20
申请人： Toshiharu Ohta , Satoshi Komoriya , Toshiharu Yoshino , Kouichi Uoto , Yumi Nakamoto , Hiroyuki Naito , Akiyoshi Mochizuki , Tsutomu Nagata , Hideyuki Kanno , Noriyasu Haginoya , Kenji Yoshikawa , Masatoshi Nagamochi , Syozo Kobayashi , Makoto Ono
发明人： Toshiharu Ohta , Satoshi Komoriya , Toshiharu Yoshino , Kouichi Uoto , Yumi Nakamoto , Hiroyuki Naito , Akiyoshi Mochizuki , Tsutomu Nagata , Hideyuki Kanno , Noriyasu Haginoya , Kenji Yoshikawa , Masatoshi Nagamochi , Syozo Kobayashi , Makoto Ono
IPC分类号： C07D401/12 , A61K20060101 , A61P20060101 , A61P7/02 , A61P9/00 , A61P9/10 , A61P29/00 , C07D20060101 , C07D209/42 , C07D401/14 , C07D417/12 , C07D417/14 , C07D487/04 , C07D495/04 , C07D498/04 , C07D513/04 , C07D513/14 , C07D519/00 , C07K5/06 , C07K5/08 , C07D471/02 , A61K31/4745 , C07D43/02
CPC分类号： C07D401/12 , A61K31/428 , A61K31/429 , A61K31/4365 , A61K31/437 , A61K31/4439 , A61K31/444 , A61K31/454 , A61K31/4545 , C07D209/42 , C07D401/14 , C07D417/12 , C07D417/14 , C07D487/04 , C07D495/04 , C07D498/04 , C07D513/04 , C07D513/14 , C07K5/06191 , C07K5/0827
摘要： A compound represented by the general formula (1): Q1-Q2-T0-N(R1)-Q3-N(R2) -T1-Q4 (1) wherein R1 and R2 are hydrogen atoms or the like; Q1 is a saturated or unsaturated, 5- or 6-membered cyclic hydrocarbon group which may be substituted, or the like; Q2 is a single bond or the like; Q3 is a group in which Q5 is an alkylene group having 1 to 8 carbon atoms, or the like; and T0 and T1 are carbonyl groups or the like; a salt thereof, a solvate thereof, or an N-oxide thereof. The compound is useful as an agent for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.
摘要翻译：由通式（1）表示的化合物：<？in-line-formula description =“In-line Formulas”end =“lead”？> Q ^{1 -O（R 1） - N 3 - （R 2） - N（R 2） - T （1）<？in-line-formula description =“In-line Formulas”end =“tail”？>其中R 1 < / SUP>和R 2是氢原子等; Q 1是可被取代的饱和或不饱和的5或6元环烃基，等等; Q 2是单键等; Q 3是其中Q 5是具有1〜8个碳原子的亚烷基等的基团; T 0和T 1是羰基等; 其盐，其溶剂合物或其N-氧化物。该化合物可用作预防和/或治疗脑梗塞，脑栓塞，心肌梗死，心绞痛，肺梗塞，肺栓塞，Buerger病，深静脉血栓形成，弥散性血管内凝血综合征，瓣膜或关节置换后血栓形成，血管成形术后的血栓形成和再闭塞，全身炎症反应综合征（SIRS），多器官功能障碍综合征（MODS），体外循环期间的血栓形成或血液抽血时的凝血。}

36. 发明申请

US20050117619A1 Semiconductor laser device and method of manufacturing the same 有权
标题翻译：半导体激光器件及其制造方法
公开(公告)号：US20050117619A1
公开(公告)日：2005-06-02
申请号：US10994436
申请日：2004-11-23
申请人： Kouji Makita , Kenji Yoshikawa , Takayuki Kashima , Hideto Adachi
发明人： Kouji Makita , Kenji Yoshikawa , Takayuki Kashima , Hideto Adachi
IPC分类号： H01S5/30 , H01S5/00 , H01S5/042 , H01S5/22 , H01S5/323
CPC分类号： H01S5/22 , H01S5/0425 , H01S5/222 , H01S5/32325
摘要： The present invention aims to provide a semiconductor laser device which has a structure that is easy to manufacture, a satisfactory temperature characteristic as well as high-speed response characteristic, and is comprised of the following: an n-type GaAs substrate 101; an n-type AlGaInP cladding layer 102 formed on the n-type GaAs substrate 101; a non-doped quantum well active layer 103; a p-type AlGaInP first cladding layer 104; a p-type GaInP etching stop layer 105; a p-type AlGaInP second cladding layer 106; a p-type GaInP cap layer 107; a p-type GaAs contact layer 108; an n-type AlInP block layer 109, has a ridge portion and convex portions formed on the both sides of the ridge portion, and the p-type GaAs contact layer 108 is formed on the ridge portion only.
摘要翻译：本发明旨在提供一种具有容易制造，令人满意的温度特性以及高速响应特性的结构的半导体激光器件，它包括：n型GaAs衬底101; 形成在n型GaAs衬底101上的n型AlGaInP包层102; 非掺杂量子阱有源层103; p型AlGaInP第一包覆层104; p型GaInP蚀刻停止层105; p型AlGaInP第二包覆层106; p型GaInP覆盖层107; p型GaAs接触层108; n型AlInP阻挡层109具有形成在脊部两侧的脊部和凸部，并且p型GaAs接触层108仅形成在脊部上。

37. 发明授权

US06769230B2 Collective and centralized inventory storing method of sheet metal parts for repairing 失效
标题翻译：钣金零件的集体集中存货方式进行维修
公开(公告)号：US06769230B2
公开(公告)日：2004-08-03
申请号：US10209275
申请日：2002-08-01
申请人： Akira Handa , Kenji Yoshikawa , Masato Noshiro
发明人： Akira Handa , Kenji Yoshikawa , Masato Noshiro
IPC分类号： B65B1148
CPC分类号： B62D65/00 , B65G1/1371
摘要： A plurality of trimmed products 5, pressed-finished products 6, sub-component products 7 or the like which are pre-coating stages of sheet metal parts are put on top of each other as semi-finished products and collectively packed by a rust-preventive sheet 12 to provide a collective style of packing for collective storage 10. This collective packing style for collective storage 10 is stored as one packing unit. Operation timing of the collective storage is when the forecasted number of demand reaches a predetermined number, for example, when cubic volume of a metal die coincides with cubic volume for storing all quantity of the semi-finished products to be stocked. At this point, all quantity of the semi-finished products of which the demand is forecasted are collectively manufactured and stored as a stock, wherein the metal die is scrapped.
摘要翻译：将作为钣金件的预涂层的多个修剪产品5，压制成品6，副成分制品7等作为半成品放置在彼此的顶部，提供集体存放的集体式的包装方式10.集体存放10的这种集体包装方式作为一个包装单元存储。集体存储的操作时间是当预测的需求量达到预定数量时，例如当金属模具的立方体积与用于存储所有数量的待储存的半成品的立方体积相一致时。此时，要求预测的所有数量的半成品被共同制造并存储为库存，其中金属模被报废。

38. 发明授权

US06470241B2 Driving state monitoring apparatus for vehicles 有权
标题翻译：车辆驾驶状态监控装置
公开(公告)号：US06470241B2
公开(公告)日：2002-10-22
申请号：US09731044
申请日：2000-12-07
申请人： Kenji Yoshikawa
发明人： Kenji Yoshikawa
IPC分类号： G06F700
CPC分类号： B60K28/066 , B60W2520/14 , B60W2550/143
摘要： A driving state monitoring apparatus for a vehicle, for monitoring a driving state of a vehicle of a driver is disclosed. According to the apparatus, a behavior parameter indicative of a lateral movement of the vehicle and a vehicle speed are detected. A behavior reference is set according to changes in the behavior parameter. A running locus of the vehicle is calculated according to the behavior parameter, the behavior reference, and the vehicle speed. A plurality of vehicle behavior feature parameters indicative of the feature of vehicle behavior is calculated according to the running locus and it is determined whether or not the driving state of the driver is proper according to the plurality of vehicle behavior feature parameters.
摘要翻译：公开了一种用于车辆的驾驶状态监视装置，用于监视驾驶员的车辆的驾驶状态。根据该装置，检测表示车辆的横向移动的行为参数和车辆速度。行为参考根据行为参数的变化进行设置。根据行为参数，行为参考值和车速计算车辆行驶轨迹。根据行驶轨迹计算表示车辆行为特征的多个车辆行为特征参数，并且根据多个车辆行为特征参数来确定驾驶员的驾驶状态是否正确。

39. 发明授权

US5861048A Phosphorylated saccharide and method for producing the same 失效
标题翻译：磷酸化糖及其制备方法
公开(公告)号：US5861048A
公开(公告)日：1999-01-19
申请号：US514478
申请日：1995-08-11
申请人： Hiroshi Kamasaka , Shigetaka Okada , Kaname Kusaka , Kazuya Yamamoto , Kenji Yoshikawa
发明人： Hiroshi Kamasaka , Shigetaka Okada , Kaname Kusaka , Kazuya Yamamoto , Kenji Yoshikawa
IPC分类号： C12P19/14 , A23L1/0526 , A23L1/0532 , A23L1/054 , A23L1/09 , A23L1/304 , A23L2/52 , A61K8/73 , A61K31/70 , A61P1/02 , A61P3/00 , A61P3/14 , A61Q11/00 , C05B15/00 , C05F11/00 , C07H1/02 , C07H3/06 , C07H11/04 , C08B31/06 , C08B37/00 , C11D3/22 , C12P19/18 , C12P19/20 , C12P19/22 , C05F3/00 , A23G3/00 , C07H1/00 , C11D17/00
CPC分类号： C07H11/04 , A23L2/52 , A23L29/238 , A23L29/256 , A23L29/27 , A23L29/272 , A23L29/273 , A23L29/35 , A23L33/16 , A61K8/732 , A61Q11/00 , C05B15/00 , C05F11/00 , C07H3/06 , C08B31/066 , C08B37/00 , C11D3/228
摘要： Phosphorylated saccharide of the present invention includes at least one phosphate group in its molecule, selected from the group consisting of glucan, mannan, dextran, agar, cyclodextrin, fucoidan, gellan gum, Locust bean gum, guar gum, tamarind gum, and xanthan gum.
摘要翻译：本发明的磷酸化糖包括分子中至少一个磷酸基团，选自葡聚糖，甘露聚糖，葡聚糖，琼脂，环糊精，岩藻依聚糖，结冷胶，刺槐豆胶，瓜尔胶，罗望子胶，黄原胶。

40. 发明授权

US08486583B2 Fuel cell with electrode having an electrically conductive nano-column and production method thereof 失效
标题翻译：具有导电性纳米柱的电极的燃料电池及其制造方法
公开(公告)号：US08486583B2
公开(公告)日：2013-07-16
申请号：US12293667
申请日：2007-03-15
申请人： Haruyuki Nakanishi , Chikashi Inazumi , Yuki Sairyo , Momoyo Sawai , Kenji Yoshikawa , Tomoya Yamashita
发明人： Haruyuki Nakanishi , Chikashi Inazumi , Yuki Sairyo , Momoyo Sawai , Kenji Yoshikawa , Tomoya Yamashita
IPC分类号： H01M4/02
CPC分类号： H01M4/8657 , H01M4/8605 , H01M4/92 , H01M4/926 , H01M8/1004 , Y02P70/56
摘要： In a fuel cell including an electrolyte membrane and a pair of electrodes disposed on both sides of the electrolyte membrane, at least one of the electrodes has an electrically conductive nanocolumn that is oriented with an inclination of 60° or less with respect to a planar direction of the electrolyte membrane, a catalyst supported on the electrically conductive nanocolumn, and an electrolyte resin coating the electrically conductive nanocolumn.
摘要翻译：在包括电解质膜和设置在电解质膜的两侧的一对电极的燃料电池中，至少一个电极具有相对于平面方向倾斜60°或更小的导电纳米柱的电解质膜，负载在导电性纳米柱上的催化剂和涂覆导电性纳米柱的电解质树脂。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式